• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
TechNeuralink

A major medical ethics group just asked the FDA to disqualify data from Elon Musk’s Neuralink animal experiments: ‘We want the FDA to proactively launch an investigation’

Prarthana Prakash
By
Prarthana Prakash
Prarthana Prakash
Europe Business News Reporter
Down Arrow Button Icon
Prarthana Prakash
By
Prarthana Prakash
Prarthana Prakash
Europe Business News Reporter
Down Arrow Button Icon
December 13, 2022, 2:56 PM ET
Elon Musk
In November, Elon Musk said that implants on human brains were roughly six months away.CARINA JOHANSEN—NTB/AFP/Getty Images

Elon Musk has several different businesses, from making electric cars at Tesla to building rocket ships at SpaceX. But one of his lesser-known businesses has been in the spotlight lately over accusations that it needlessly killed about 1,500 animals. 

Neuralink, Musk’s brain technology startup, has come under fire recently for its animal testing practices, and the company is being investigated for violations of animal welfare. Over 20 current and former employees claim that the tests were being conducted hastily, and that workers were under pressure from Musk to expedite trials, leading to botched experiments and excessive animal deaths.   

Now, a major medical ethics advocacy group, the Physicians Committee for Responsible Medicine, has requested the Food and Drug Administration hold Neuralink accountable for violating protocols on biological tests, and disqualify the data obtained from animal testing, the Washington Post reported Tuesday. It has also asked the FDA to ban additional animal tests by Neuralink.

“Between what we’ve seen in public records and what has been reported, it’s hard to imagine that Neuralink’s animal experiments meet FDA’s requirements,” Deborah Dubow Press, associate general counsel with the Physicians Committee, said in a statement.

In an interview with Fortune, Ryan Merkley, director of research advocacy for the organization, said that it was concerned that the documents Neuralink was providing to the FDA were not “trustworthy.”

“We want FDA to take a very close look at whatever Neuralink is providing, and ideally, we want the FDA to proactively launch an investigation because it’s clear that over the years from public records and whistleblower reports that Neuralink has not followed its own internal protocols.”

Neuralink did not reply to Fortune’s request for comment.

If the FDA does dismiss the results collected thus far, it could threaten Neuralink’s business plans for its brain implants and the company’s stated vision of creating a “brain-computer interface.” At a Neuralink event in November, Musk said that implants on human brains were roughly six months away and that the company had already submitted its request to the FDA. He presented a video of a monkey named Pager playing “monkey mind pong,” which resembles ping-pong but he plays it in his mind. Musk claimed that Pager would not be able to do so without using a brain implant, which he described as “replacing a piece of the skull with a smartwatch.”

“Before we would even think of putting a device in an animal, we do everything we possibly can with rigorous benchtop testing, so we are not cavalier,” Musk said during the presentation. He also said that whenever a device was implanted into a sheep, pig, or monkey, it was done to confirm their testing results rather than to explore the outcomes of the experiment on the animal.

The Physicians Committee for Responsible Medicine based its request to the FDA on 700 pages’ worth of documents that were obtained after suing the California National Primate Research Center at the University of California–Davis, which was tasked with conducting the Neuralink animal experiments. The tests were conducted on rhesus macaques, a pink-faced species of monkey originating in Asia, the Washington Post reported.  

Our new weekly Impact Report newsletter examines how ESG news and trends are shaping the roles and responsibilities of today's executives. Subscribe here.

About the Author
Prarthana Prakash
By Prarthana PrakashEurope Business News Reporter
LinkedIn icon

Prarthana Prakash was a Europe business reporter at Fortune.

See full bioRight Arrow Button Icon

Latest in Tech

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Tech

InnovationJobs
‘Wake up, AI is for real.’ IMF chief warns of an AI ‘tsunami’ coming for young people and entry-level jobs
By Tristan BoveJanuary 23, 2026
35 minutes ago
anxiety
Future of WorkAnxiety
AI anxiety is so widespread that veteran Microsoft researchers are having panic attacks because they’re making themselves obsolete
By Patrick Barry and The ConversationJanuary 23, 2026
1 hour ago
hassabis
InvestingPharmaceutical Industry
Inside Big Pharma and VC’s big bet on AI: You wouldn’t ‘want to fly an airplane designed by hand, but all of our drugs are designed like that’
By Nick LichtenbergJanuary 23, 2026
1 hour ago
trump, xi
PoliticsTikTok
Trump thanks Xi, hails himself for closing TikTok deal: ‘Long into the future I will be remembered by those who use and love TikTok’
By Kaitlyn Huamani and The Associated PressJanuary 23, 2026
3 hours ago
shubham
CommentaryConsulting
When AI meets healthcare, how should payers react? 
By Shubham SinghalJanuary 23, 2026
4 hours ago
kass
Future of WorkBook Excerpt
The real cost of job automation isn’t economic, it’s identity 
By Zack KassJanuary 23, 2026
4 hours ago

Most Popular

placeholder alt text
Economy
'Some form of crisis is almost inevitable': The $38 trillion national debt will soon be growing faster than the U.S. economy itself, watchdog warns
By Nick LichtenbergJanuary 22, 2026
24 hours ago
placeholder alt text
Success
Nvidia CEO Jensen Huang says ‘a lot’ of six-figure jobs in plumbing and construction are about to be unlocked because someone needs to build all these new AI centers
By Preston ForeJanuary 21, 2026
2 days ago
placeholder alt text
Energy
Elon Musk warns the U.S. could soon be producing more chips than we can turn on. And China doesn’t have the same issue
By Sasha RogelbergJanuary 22, 2026
1 day ago
placeholder alt text
Politics
Jamie Dimon tells Davos: ‘You didn’t do a particularly good job making the world a better place’
By Eleanor PringleJanuary 21, 2026
2 days ago
placeholder alt text
Europe
Denmark offered to trade Greenland to the U.S. in 1910—and America thought it was crazy
By Steven Lamy and The ConversationJanuary 22, 2026
1 day ago
placeholder alt text
Success
McDonald’s CEO shares tough love career advice he’d give Gen Z and young millennial workers: ‘No one cares about your career’
By Orianna Rosa RoyleJanuary 22, 2026
1 day ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.